xBrane - About the company
xBrane is a public company based in Solna (Sweden), founded in 2008. It operates as a Swedish Biopharmaceutical company developing biosimilars and long-acting injectables for existing drugs. xBrane has raised an undisclosed amount in funding.
Company Details
X-Brane is a Swedish Biopharmaceutical company developing biosimilars and long-acting injectables for existing drugs. The long-acting drugs are based on xBrane's microsphere technology based on biodegradable polymers which release the drug over 1-6 months. Their lead candidate based on microspheres is SPHEROTIDE, a GnRH analog called Triptorelin, and the controlled release is by encapsulation in biopolymers. They also work on biosimilars. The lead biosimilar candidate is XLUCANE, a biosimilar of Lucentis, indicated for age-related macular degeneration.
- Website
- xbrane.com/en/
- Email ID
- *****@xbrane.com
xBrane's IPO details
xBrane got listed on Feb 03, 2016.
Click here to take a look at xBrane's IPO in detail
Sign up to download xBrane's company profile
xBrane's funding and investors
xBrane has raised funding over 4 rounds. Its first funding round was on Oct 28, 2008. xBrane has 6 institutional investors.
Here is the list of recent funding rounds of xBrane:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 22, 2017 | 6304372 | Conventional Debt | 2863967 | 5053601 | 1967411 | 9776766 |
Mar 05, 2012 | 1616093 | Grant (prize money) | 2160925 | 2503355 | 8240191 | |
Mar 03, 2011 | 7758907 | Grant (prize money) | 9814090 | 7552192 | 9891009 |
View details of xBrane's funding rounds and investors
xBrane's founders and board of directors
Founder? Claim ProfilexBrane's employee count trend
xBrane has 71 employees as of Jul 24. Here is xBrane's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
xBrane's Investments and acquisitions
xBrane has acquired 2 companies including Primm and Primmbiotech. xBrane has not made any investments as of now.Reports related to xBrane
Here is the latest report on xBrane's sector:
News related to xBrane
Media has covered xBrane for a total of 2 events in the last 1 year.
•
Alvotech acquires Xbrane’s R&D operations in Sweden and biosimilar candidate XB003Seeking Alpha•Mar 20, 2025•Alvotech, xBrane
•
Alvotech expands biosimilar R&D, solidifying global leadership.Benzinga•Mar 20, 2025•Alvotech, xBrane
•
•
•
STADA and Xbrane launch Ximluci ranibizumab biosimilar in EuropePipelinereview•Apr 03, 2023•Stada, xBrane
•
•
•
•
•
Are you a Founder ?
FAQs about xBrane
Explore our recently published companies
- ConKey - Sao Bernardo do Campo based, 2023 founded, Acquired company
- Israeltoday - Netherlands based, Unfunded company
- Ejc - Netherlands based, 1992 founded, Funding Raised company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- PSQUARE INTERIOR FURNISHING PRIVATE LIMITED - 1997 founded, Unfunded company
- Upper India Steel Mfg & Enggineering Company - Chandigarh based, 1961 founded, Unfunded company